463 related articles for article (PubMed ID: 20616797)
1. Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia.
Kharas MG; Lengner CJ; Al-Shahrour F; Bullinger L; Ball B; Zaidi S; Morgan K; Tam W; Paktinat M; Okabe R; Gozo M; Einhorn W; Lane SW; Scholl C; Fröhling S; Fleming M; Ebert BL; Gilliland DG; Jaenisch R; Daley GQ
Nat Med; 2010 Aug; 16(8):903-8. PubMed ID: 20616797
[TBL] [Abstract][Full Text] [Related]
2. Musashi 2 in hematopoiesis.
de Andrés-Aguayo L; Varas F; Graf T
Curr Opin Hematol; 2012 Jul; 19(4):268-72. PubMed ID: 22517588
[TBL] [Abstract][Full Text] [Related]
3. Up-regulated MSI2 is associated with more aggressive chronic myeloid leukemia.
Kaeda J; Ringel F; Oberender C; Mills K; Quintarelli C; Pane F; Koschmieder S; Slany R; Schwarzer R; Saglio G; Hemmati P; van Lessen A; Amini L; Gresse M; Vagge E; Burmeister T; Serra A; Carson A; Schwarz M; Westermann J; Jundt F; Dörken B; le Coutre P
Leuk Lymphoma; 2015 Jul; 56(7):2105-13. PubMed ID: 25363400
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemia.
Thol F; Winschel C; Sonntag AK; Damm F; Wagner K; Chaturvedi A; Göhring G; Schlegelberger B; Lübbert M; Fiedler W; Kirchner H; Krauter J; Ganser A; Heuser M
Ann Hematol; 2013 Mar; 92(3):315-23. PubMed ID: 23233047
[TBL] [Abstract][Full Text] [Related]
5. Musashi-2 Silencing Exerts Potent Activity against Acute Myeloid Leukemia and Enhances Chemosensitivity to Daunorubicin.
Han Y; Ye A; Zhang Y; Cai Z; Wang W; Sun L; Jiang S; Wu J; Yu K; Zhang S
PLoS One; 2015; 10(8):e0136484. PubMed ID: 26308531
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-143 acts as a tumor suppressor through Musashi-2/DLL1/Notch1 and Musashi-2/Snail1/MMPs axes in acute myeloid leukemia.
Li F; Han Y; Chen R; Jiang Y; Chen C; Wang X; Zhou J; Xu Q; Jiang S; Zhang S; Yu K; Zhang S
J Transl Med; 2023 May; 21(1):309. PubMed ID: 37149661
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS.
Barreyro L; Will B; Bartholdy B; Zhou L; Todorova TI; Stanley RF; Ben-Neriah S; Montagna C; Parekh S; Pellagatti A; Boultwood J; Paietta E; Ketterling RP; Cripe L; Fernandez HF; Greenberg PL; Tallman MS; Steidl C; Mitsiades CS; Verma A; Steidl U
Blood; 2012 Aug; 120(6):1290-8. PubMed ID: 22723552
[TBL] [Abstract][Full Text] [Related]
9. Identification of gene targets of mutant C/EBPα reveals a critical role for MSI2 in CEBPA-mutated AML.
Heyes E; Schmidt L; Manhart G; Eder T; Proietti L; Grebien F
Leukemia; 2021 Sep; 35(9):2526-2538. PubMed ID: 33623142
[TBL] [Abstract][Full Text] [Related]
10. [Expression of musashi-2 gene in leukemia stem cells from acute myeloid leukemia patients].
Ye AF; Han YX; Zhang SH; Li HY; Chen CQ; Wu JB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1235-8. PubMed ID: 25338564
[TBL] [Abstract][Full Text] [Related]
11. Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target.
Palacios F; Yan XJ; Ferrer G; Chen SS; Vergani S; Yang X; Gardner J; Barrientos JC; Rock P; Burack R; Kolitz JE; Allen SL; Kharas MG; Abdel-Wahab O; Rai KR; Chiorazzi N
Leukemia; 2021 Apr; 35(4):1037-1052. PubMed ID: 33504942
[TBL] [Abstract][Full Text] [Related]
12. Runx2 induces acute myeloid leukemia in cooperation with Cbfbeta-SMMHC in mice.
Kuo YH; Zaidi SK; Gornostaeva S; Komori T; Stein GS; Castilla LH
Blood; 2009 Apr; 113(14):3323-32. PubMed ID: 19179305
[TBL] [Abstract][Full Text] [Related]
13. Musashi2 modulates K562 leukemic cell proliferation and apoptosis involving the MAPK pathway.
Zhang H; Tan S; Wang J; Chen S; Quan J; Xian J; Zhang Ss; He J; Zhang L
Exp Cell Res; 2014 Jan; 320(1):119-27. PubMed ID: 24076374
[TBL] [Abstract][Full Text] [Related]
14. MSI2 protein expression predicts unfavorable outcome in acute myeloid leukemia.
Byers RJ; Currie T; Tholouli E; Rodig SJ; Kutok JL
Blood; 2011 Sep; 118(10):2857-67. PubMed ID: 21753187
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of HOXB4 in de novo acute myeloid leukemia.
Umeda S; Yamamoto K; Murayama T; Hidaka M; Kurata M; Ohshima T; Suzuki S; Sugawara E; Kawano F; Kitagawa M
Hematology; 2012 May; 17(3):125-31. PubMed ID: 22664110
[TBL] [Abstract][Full Text] [Related]
16. Musashi2 sustains the mixed-lineage leukemia-driven stem cell regulatory program.
Park SM; Gönen M; Vu L; Minuesa G; Tivnan P; Barlowe TS; Taggart J; Lu Y; Deering RP; Hacohen N; Figueroa ME; Paietta E; Fernandez HF; Tallman MS; Melnick A; Levine R; Leslie C; Lengner CJ; Kharas MG
J Clin Invest; 2015 Mar; 125(3):1286-98. PubMed ID: 25664853
[TBL] [Abstract][Full Text] [Related]
17. Knock-out of Hopx disrupts stemness and quiescence of hematopoietic stem cells in mice.
Lin CC; Yao CY; Hsu YC; Hou HA; Yuan CT; Li YH; Kao CJ; Chuang PH; Chiu YC; Chen Y; Chou WC; Tien HF
Oncogene; 2020 Jul; 39(28):5112-5123. PubMed ID: 32533098
[TBL] [Abstract][Full Text] [Related]
18. Targeting the RNA m
Paris J; Morgan M; Campos J; Spencer GJ; Shmakova A; Ivanova I; Mapperley C; Lawson H; Wotherspoon DA; Sepulveda C; Vukovic M; Allen L; Sarapuu A; Tavosanis A; Guitart AV; Villacreces A; Much C; Choe J; Azar A; van de Lagemaat LN; Vernimmen D; Nehme A; Mazurier F; Somervaille TCP; Gregory RI; O'Carroll D; Kranc KR
Cell Stem Cell; 2019 Jul; 25(1):137-148.e6. PubMed ID: 31031138
[TBL] [Abstract][Full Text] [Related]
19. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs expressed in hematopoietic stem/progenitor cells are deregulated in acute myeloid leukemias.
Testa U; Pelosi E
Leuk Lymphoma; 2015 May; 56(5):1466-74. PubMed ID: 25242094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
